{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:45:08Z","timestamp":1792449908805,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.gtc.2021.02.008","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T11:39:23Z","timestamp":1619177963000},"page":"463-474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Small Intestinal Bacterial Overgrowth"],"prefix":"10.1016","volume":"50","author":[{"given":"Daniel","family":"Bushyhead","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamonn M.","family":"Quigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gtc.2021.02.008_bib1","first-page":"215","article-title":"Macrocytic anemia in association with intestinal strictures and anastomoses: review of literature and report of 2 new cases","volume":"64","author":"Barker","year":"1939","journal-title":"Bull Johns Hopkins Hosp"},{"key":"10.1016\/j.gtc.2021.02.008_bib2","doi-asserted-by":"crossref","first-page":"e1002533","DOI":"10.1371\/journal.pbio.1002533","article-title":"Revised Estimates for the Number of Human and Bacteria Cells in the Body","volume":"14","author":"Sender","year":"2016","journal-title":"PLoS Biol"},{"key":"10.1016\/j.gtc.2021.02.008_bib3","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Microbiology: Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.gtc.2021.02.008_bib4","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1572-0241.1999.01016.x","article-title":"Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome","volume":"94","author":"Bouhnik","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2021.02.008_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fphys.2019.00185","article-title":"Intestinal Bacteria Interplay With Bile and Cholesterol Metabolism: Implications on Host Physiology","volume":"10","author":"Molinero","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.gtc.2021.02.008_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00004836-200603000-00015","article-title":"Colonic health: fermentation and short chain fatty acids","volume":"40","author":"Wong","year":"2006","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.gtc.2021.02.008_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.gtc.2021.02.008_bib8","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1007\/BF01295987","article-title":"Gastrointestinal motility disorders","volume":"31","author":"Vantrappen","year":"1986","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2021.02.008_bib9","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.3748\/wjg.v18.i46.6801","article-title":"Ileocecal valve dysfunction in smallintestinal bacterial overgrowth: a pilot study","volume":"18","author":"Miller","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gtc.2021.02.008_bib10","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s10620-014-3166-7","article-title":"Low ileocecal valve pressure is significantly associated with small intestinal bacterial overgrowth (SIBO)","volume":"59","author":"Roland","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2021.02.008_bib11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cgh.2009.12.022","article-title":"Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy","volume":"8","author":"Lombardo","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2021.02.008_bib12","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ajg.2012.4","article-title":"Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth","volume":"107","author":"Ratuapli","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2021.02.008_bib13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/2050640616630117","article-title":"Systematic review and meta-analysis: small intestinal bacterial overgrowth in chronic pancreatitis","volume":"4","author":"Capurso","year":"2016","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.gtc.2021.02.008_bib14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cgh.2011.02.031","article-title":"Immune dysfunction and infections in patients with cirrhosis","volume":"9","author":"Bonnel","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2021.02.008_bib15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.gtc.2011.09.005","article-title":"Chronic intestinal pseudo-obstruction: clinical features, diagnosis, and therapy","volume":"40","author":"De Giorgio","year":"2011","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.gtc.2021.02.008_bib16","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1007\/BF01296621","article-title":"Breath hydrogen test using water-diluted lactulose in patients with gastrointestinal amyloidosis","volume":"36","author":"Matsumoto","year":"1991","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2021.02.008_bib17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/MCG.0b013e3181d6bc3e","article-title":"The thyroid and the gut","volume":"44","author":"Ebert","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.gtc.2021.02.008_bib18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/gut.31.8.879","article-title":"Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes","volume":"31","author":"Pignata","year":"1990","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2021.02.008_bib19","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00431-010-1235-2","article-title":"Clinical practice. Protein-losing enteropathy in children","volume":"169","author":"Braamskamp","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.gtc.2021.02.008_bib20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.5858\/134.2.264","article-title":"Small intestinal bacterial overgrowth: histopathologic features and clinical correlates in an underrecognized entity","volume":"134","author":"Lappinga","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.gtc.2021.02.008_bib21","doi-asserted-by":"crossref","first-page":"e00078","DOI":"10.14309\/ctg.0000000000000078","article-title":"Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management","volume":"10","author":"Rao","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.gtc.2021.02.008_bib22","doi-asserted-by":"crossref","first-page":"1443e54","DOI":"10.1007\/s10620-007-0065-1","article-title":"A\u00a0systematic review of diagnostic tests for small intestinal bacterial overgrowth","volume":"53","author":"Khoshini","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2021.02.008_bib23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/nmo.12516","article-title":"Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test","volume":"27","author":"Erdogan","year":"2015","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.gtc.2021.02.008_bib24","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/apt.13622","article-title":"Characterisation of the gastrointestinal mucosa-associated microbiota: a novel technique to prevent cross-contamination during endoscopic procedures","volume":"43","author":"Shanahan","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2021.02.008_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrgastro.2012.44","article-title":"Techniques used to characterize the intestinal microbiota: A guide for the clinician","volume":"9","author":"Fraher","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2021.02.008_bib26","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3390\/microorganisms3040866","article-title":"Hydrogen sulfide in physiology and diseases of the digestive tract","volume":"3","author":"Singh","year":"2015","journal-title":"Microorganisms"},{"key":"10.1016\/j.gtc.2021.02.008_bib27","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/ajg.2017.46","article-title":"Hydrogen and methane-based breath testing in gastrointestinal disorders: the north american consensus","volume":"112","author":"Rezaie","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2021.02.008_bib28","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1007\/s10620-011-1590-5","article-title":"Methane on breath testing is associated with constipation: a systematic review and meta-analysis","volume":"56","author":"Kunkel","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2021.02.008_bib29","doi-asserted-by":"crossref","first-page":"G1089","DOI":"10.1152\/ajpgi.00574.2004","article-title":"Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestine contractile activity","volume":"290","author":"Pimentel","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.gtc.2021.02.008_bib30","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.cgh.2013.09.055","article-title":"Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy","volume":"12","author":"Saad","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2021.02.008_bib31","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/gut.2009.205476","article-title":"Combined oro-cecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-cecal transit, not small intestinal bacterial overgrowth in patients with IBS","volume":"60","author":"Yu","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2021.02.008_bib32","doi-asserted-by":"crossref","first-page":"e13350Q","DOI":"10.1111\/nmo.13350","article-title":"Does glucose-based hydrogen and methane breath test detect bacterial overgrowth in the jejunum?","volume":"30","author":"Sundin","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.gtc.2021.02.008_bib33","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/ajg.2017.373","article-title":"Response to Paterson et\u00a0al","volume":"112","author":"Rezaie","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2021.02.008_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.14309\/ajg.0000000000000501","article-title":"ACG clinical guideline: small intestinal bacterial overgrowth","volume":"115","author":"Pimentel","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2021.02.008_bib35","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1056\/NEJM199111213252102","article-title":"Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma","volume":"325","author":"Soudah","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gtc.2021.02.008_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation","volume":"364","author":"Pimentel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gtc.2021.02.008_bib37","first-page":"51","article-title":"Pharmacokinetic study of rifaximin after oral administration in healthy volunteers","volume":"14","author":"Descombe","year":"1994","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1016\/j.gtc.2021.02.008_bib38","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1128\/AAC.00161-10","article-title":"Bile acids improve the antimicrobial effect of rifaximin","volume":"54","author":"Darkoh","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.gtc.2021.02.008_bib39","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.13928","article-title":"Systematic review with meta-analysis: Rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth","volume":"45","author":"Gatta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2021.02.008_bib40","first-page":"412","article-title":"Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: A double-blind, randomized, placebo-controlled study","volume":"98","author":"Pimentel","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2021.02.008_bib41","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/MCG.0b013e3181c64c90","article-title":"A\u00a0combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test","volume":"44","author":"Low","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.gtc.2021.02.008_bib42","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/01.meg.0000223906.55245.61","article-title":"Endogenous ethanol production in a patient with chronic intestinal pseudo-obstruction and small intestinal bacterial overgrowth","volume":"18","author":"Spinucci","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2021.02.008_bib43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0000000000000814","article-title":"Probiotics for preventing and treating small intestinal bacterial overgrowth: A meta-analysis and systematic review of current evidence","volume":"51","author":"Zhong","year":"2017","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.gtc.2021.02.008_bib44","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ajg.2016.472","article-title":"Irritable bowel syndrome-like symptoms following fecal microbiota transplantation: A possible donor-dependent complication","volume":"112","author":"Chang","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2021.02.008_bib45","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/pds.1547","article-title":"Adverse events associated with prolonged antibiotic use","volume":"17","author":"Meropol","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.gtc.2021.02.008_bib46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.gastro.2019.03.049","article-title":"Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review","volume":"157","author":"Pittayanon","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2021.02.008_bib47","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.cgh.2009.06.031","article-title":"Small intestinal bacterial overgrowth in irritable bowel syndrome: Systematic review and meta-analysis","volume":"7","author":"Ford","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2021.02.008_bib48","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1111\/j.1572-0241.2008.01992.x","article-title":"Bacterial overgrowth and irritable bowel syndrome: Unifying hypothesis or a spurious consequence of proton pump inhibitors?","volume":"103","author":"Spiegel","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2021.02.008_bib49","doi-asserted-by":"crossref","first-page":"190","DOI":"10.14309\/ajg.0000000000000504","article-title":"Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies","volume":"115","author":"Shah","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2021.02.008_bib50","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2019.05.056","article-title":"Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin","volume":"157","author":"Moayyedi","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2021.02.008_bib51","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ajg.2011.355","article-title":"The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis","volume":"107","author":"Menees","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2021.02.008_bib52","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/ajg.2015.220","article-title":"Altered colonic bacterial fermentation as a potential pathophysiological factor in irritable bowel syndrome","volume":"110","author":"Ringel-Kulka","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2021.02.008_bib53","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cgh.2011.02.030","article-title":"Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: An epidemiologic and evolutionary perspective","volume":"9","author":"Spiegel","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2021.02.008_bib54","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3109\/00365521.2015.1027261","article-title":"Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome","volume":"50","author":"Giamarellos-Bourboulis","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gtc.2021.02.008_bib55","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s11938-018-0207-x","article-title":"Gastroduodenal \"dysbiosis\": a new clinical entity","volume":"16","author":"Shah","year":"2018","journal-title":"Curr Treat Options Gastroenterol"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855321000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855321000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:31:41Z","timestamp":1760178701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855321000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0889855321000200"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2021.02.008","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small Intestinal Bacterial Overgrowth","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2021.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}